Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 2
2018 4
2019 3
2020 1
2021 3
2022 2
2023 2
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial.
López-Cortés LE, Delgado-Valverde M, Moreno-Mellado E, Goikoetxea Aguirre J, Guio Carrión L, Blanco Vidal MJ, López Soria LM, Pérez-Rodríguez MT, Martínez Lamas L, Arnaiz de Las Revillas F, Armiñanzas C, Ruiz de Alegría-Puig C, Jiménez Aguilar P, Del Carmen Martínez-Rubio M, Sáez-Bejar C, de Las Cuevas C, Martín-Aspas A, Galán F, Yuste JR, Leiva-León J, Bou G, Capón González P, Boix-Palop L, Xercavins-Valls M, Goenaga-Sánchez MÁ, Anza DV, Castón JJ, Rufián MR, Merino E, Rodríguez JC, Loeches B, Cuervo G, Guerra Laso JM, Plata A, Pérez Cortés S, López Mato P, Sierra Monzón JL, Rosso-Fernández C, Bravo-Ferrer JM, Retamar-Gentil P, Rodríguez-Baño J; SIMPLIFY study group. López-Cortés LE, et al. Among authors: bravo ferrer jm. Lancet Infect Dis. 2024 Apr;24(4):375-385. doi: 10.1016/S1473-3099(23)00686-2. Epub 2024 Jan 9. Lancet Infect Dis. 2024. PMID: 38215770 Clinical Trial.
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA).
Pérez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J, Sojo-Dorado J, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Reguera JM, Valiente de Santis L, Torre-Cisneros J, Cano Á, Roilides E, Radulovic L, Kirakli C, Shaw E, Falagas ME, Pintado V, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodriguez-Baño J; COMBACTE-CARE-EURECA Team. Pérez-Galera S, et al. Among authors: bravo ferrer jm. EClinicalMedicine. 2023 Feb 27;57:101871. doi: 10.1016/j.eclinm.2023.101871. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36895801 Free PMC article.
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA).
Paniagua-García M, Bravo-Ferrer JM, Pérez-Galera S, Kostyanev T, de Kraker MEA, Feifel J, Palacios-Baena ZR, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Cano Á, Reguera JM, Bartoloni A, Florescu SA, Benea S, Bukarica L, Asensio Á, Korten V, Grundmann H, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodríguez-Baño J; COMBACTE-CARE-EURECA team. Paniagua-García M, et al. Among authors: bravo ferrer jm. Clin Microbiol Infect. 2024 Feb;30(2):223-230. doi: 10.1016/j.cmi.2023.11.008. Clin Microbiol Infect. 2024. PMID: 38267096 Free article.
Endocarditis caused by anaerobic bacteria.
Kestler M, Muñoz P, Marín M, Goenaga MA, Idígoras Viedma P, de Alarcón A, Lepe JA, Sousa Regueiro D, Bravo-Ferrer JM, Pajarón M, Costas C, García-López MV, Hidalgo-Tenorio C, Moreno M, Bouza E; Spanish Collaboration on Endocarditis (GAMES). Kestler M, et al. Among authors: bravo ferrer jm. Anaerobe. 2017 Oct;47:33-38. doi: 10.1016/j.anaerobe.2017.04.002. Epub 2017 Apr 5. Anaerobe. 2017. PMID: 28389412
Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: A post hoc emulation trial of the SIMPLIFY trial.
Rando E, Delgado-Valverde M, Aguirre JG, Carrión LG, Vidal MJB, Andrés JLB, Rodríguez MTP, Lamas LM, Arnaiz de Las Revillas F, Armiñanzas C, de Alegría-Puig CR, Aguilar PJ, Martínez-Rubio MDC, Sáez-Béjar C, de Las Cuevas C, Martín-Aspas A, Galán F, Yuste JR, Leiva-León J, Bou G, González PC, Boix-Palop L, Xercavins-Valls M, Goenaga-Sánchez MÁ, Anza DV, Castón JJ, Rufián MR, Merino E, Rodríguez JC, Loeches B, Rosso-Fernández C, Bravo-Ferrer JM, Retamar-Gentil P, Rodríguez-Baño J, Cortés LEL; SIMPLIFY Study Group. Rando E, et al. Among authors: bravo ferrer jm. Int J Infect Dis. 2025 Jul;156:107917. doi: 10.1016/j.ijid.2025.107917. Epub 2025 Apr 29. Int J Infect Dis. 2025. PMID: 40311800 Free article. Clinical Trial.
A Contemporary Picture of Enterococcal Endocarditis.
Pericàs JM, Llopis J, Muñoz P, Gálvez-Acebal J, Kestler M, Valerio M, Hernández-Meneses M, Goenaga MÁ, Cobo-Belaustegui M, Montejo M, Ojeda-Burgos G, Sousa-Regueiro MD, de Alarcón A, Ramos-Martínez A, Miró JM; GAMES Investigators. Pericàs JM, et al. J Am Coll Cardiol. 2020 Feb 11;75(5):482-494. doi: 10.1016/j.jacc.2019.11.047. J Am Coll Cardiol. 2020. PMID: 32029130 Free article.
Left-sided infective endocarditis in patients with liver cirrhosis.
Ruiz-Morales J, Ivanova-Georgieva R, Fernández-Hidalgo N, García-Cabrera E, Miró JM, Muñoz P, Almirante B, Plata-Ciézar A, González-Ramallo V, Gálvez-Acebal J, Fariñas MC, Bravo-Ferrer JM, Goenaga-Sánchez MA, Hidalgo-Tenorio C, Goikoetxea-Agirre J, de Alarcón-González A; Spanish Collaboration on Endocarditis Group-Grupo de Apoyo al Manejo de la Endocarditis en España (GAMES); Spanish Network for Research in Infectious Diseases (REIPI). Ruiz-Morales J, et al. Among authors: bravo ferrer jm. J Infect. 2015 Dec;71(6):627-41. doi: 10.1016/j.jinf.2015.09.005. Epub 2015 Sep 25. J Infect. 2015. PMID: 26408206
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM): Protocol for a randomized, pragmatic trial.
Garrigós C, Rosso-Fernández CM, Borreguero I, Rodríguez P, García-Albea R, Bravo-Ferrer JM, Rodríguez-Baño J, Del Toro MD; DURATIOM team. Garrigós C, et al. Among authors: bravo ferrer jm. PLoS One. 2023 May 22;18(5):e0286094. doi: 10.1371/journal.pone.0286094. eCollection 2023. PLoS One. 2023. PMID: 37216357 Free PMC article.
High delayed mortality after the first episode of Clostridium difficile infection.
Cózar A, Ramos-Martínez A, Merino E, Martínez-García C, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez C, Cuquet J, Gil-Campesino H, Torres L, Sánchez-Porto A, Royuela A, Cobo J; Study group. Cózar A, et al. Among authors: bravo ferrer jm. Anaerobe. 2019 Jun;57:93-98. doi: 10.1016/j.anaerobe.2019.04.004. Epub 2019 Apr 5. Anaerobe. 2019. PMID: 30959165
Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score.
Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García-Rosado D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez-Camacho C, Cuquet J, Pino-Calm B, Torres L, Sánchez-Porto A, Fernández-Félix BM; Nosocomial Infection Study Group. Cobo J, et al. Among authors: bravo ferrer jm. Int J Antimicrob Agents. 2018 Mar;51(3):393-398. doi: 10.1016/j.ijantimicag.2017.09.010. Epub 2017 Sep 20. Int J Antimicrob Agents. 2018. PMID: 28939450
22 results